Back to search

Article

Neutralization of SARS-CoV-2 variants B.1.617.1 and B.1.525 by BNT162b2-elicited sera

2021-05-21

Abstract excerpt

<title>Abstract</title> <p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve around the world, generating new variants that are of concern based on their potential for altered transmissibility, pathogenicity, and coverage by vaccines and therapeutics. Here we report that 20 BNT162b2 vaccine-elicited human sera neutralize engineered SARS-CoV-2 with a USA-WA1/2020 genetic background (...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
635c7afe-0de4-5429-a17a-1b044e900bc2
DOI
10.21203/rs.3.rs-540721/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Neutralization of SARS-CoV-2 variants B.1.617.1 and B.1.525 by BNT162b2-elicited seraDOI 10.21203/rs.3.rs-540721/v1
Select a neighboring publication to make it the new centre.